Discontinued — last reported Q2 '25
Stryker Neuro Cranial - Interventional Spine — Net Sales increased by 9.3% to $129.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 31.6%, from $98.00M to $129.00M. Over 2 years (FY 2022 to FY 2024), Neuro Cranial - Interventional Spine — Net Sales shows an upward trend with a 21.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing adoption of the company's neuro-spine technologies and successful expansion in specialized surgical markets, while a decrease may signal increased competition or a slowdown in elective surgical procedure volumes.
This metric represents the total revenue generated from the sale of medical devices and equipment specifically designed...
Peers in the medical device industry report this as specialized neuro-spine or surgical technology segment revenue, often compared against competitors' dedicated neuro-interventional business units.
syk_segment_neuro_cranial_interventional_spine_net_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $70.50M | $70.50M | $70.50M | $70.50M | $81.75M | $81.75M | $81.75M | $81.75M | $98.00M | $98.00M | $100.00M | $117.00M | $118.00M | $129.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +16.0% | +0.0% | +0.0% | +0.0% | +19.9% | +0.0% | +2.0% | +17.0% | +0.9% | +9.3% |
| YoY Change | — | — | — | — | +16.0% | +16.0% | +16.0% | +16.0% | +19.9% | +19.9% | +22.3% | +43.1% | +20.4% | +31.6% |